Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 9.1 Billion | USD 13.4 Billion | 6.7% | 2021 |
FrequentlyAsked Questions
One of the key drivers fueling the expansion of the needle-free diabetes treatment market is the development of transdermal patches, which measure blood sugar levels via the skin without extracting blood.
According to the report, the global needle-free diabetes care market was worth about 9.1 (USD billion) in 2021 and is predicted to grow to around 13.4 (USD billion) by 2028, along with a compound annual growth rate (CAGR) of approximately 6.7%.
North America now monopolizes the needle-free diabetes treatment industry due to its vast diabetic population, changing lifestyle, rising healthcare costs, and adaptive population.
Some of the main competitors dominating the global needle-free diabetes care market include - European Pharma Group, Medical International Technology Inc., Antares Pharma Inc., Zogenix Inc., 3M Company, Valeritas Inc., Endo International plc., INJEX Pharma AG, and Bioject Medical Technologies Inc.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed